Product Pipeline
For more information about the BEXXAR therapeutic regimen, visit
Corixa to present at JPMorgan Healthcare Conference, Jan. 14th
Corixa awarded $11.6 M from NIH biodefense partnership
Corixa and GSK announce plans to initiate clinical study for a novel TB vaccine
Court denies Biogen Idec's motion for summary judgment and vacates previous ruling on BEXXAR patents
More News
A business overview as well as information on Corixa's partners, management team, employment opportunities, and company contacts.
Products on the market and adjuvants for research applications.
Product pipeline, therapeutic areas of focus, products, technology platforms, and publications.
Company reports, stockholder letter, events calendar, stock quote, analyst list, and materials request.
Current and archived company press releases.